Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 481 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
481
Total Funding
$1.7B
Avg Funding
$68.4M
Cities
23

Export 481 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Diego, United States
$25.0M
raised

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wexford, United States
$4.0M
raised

Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bothell, United States
$13.2M
raised

YD Bio is a biotechnology business that is developing advancements in ophthalmology and DNA methylation-based cancer detection technology.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Morgan Hill, United States
$3.0M
raised

Tenon Medical is a biotechnology company that optimizes SI joint surgical solutions.

Aug 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Melville, United States
$400.0M
raised

Sharps Technology makes single-use syringes that help prevent accidental needle sticks and make injections safer

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Emeryville, United States
$30.0M
raised

OmniAb® provides access to diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Malvern, United States
$1.9M
raised

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New Haven, United States

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lexington, United States

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

Aug 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$150.0M
raised

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Aug 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$5.0M
raised

Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Woburn, United States
$4.1M
raised

Comera Life Sciences Holdings is an engineering superior biotherapeutic formulations for fragile patients.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$120.0M
raised

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cincinnati, United States
$225.0M
raised

CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.

Aug 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$3.3M
raised

Virax Biolabs is a biotechnology company focusing on the prevention, detection, and diagnosis of viral diseases.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$50.0M
raised

Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boca Raton, United States
$8.5M
raised

Grid AI delivers innovative energy management solutions for homes, businesses, and industrial campuses.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Guilford, United States
$50.0M
raised

Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$175.0M
raised

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miramar Beach, United States
$1.6M
raised

HCW Biologics is developing immunotherapies to lengthen healthspan by disrupting the link between cellular senescence and disease.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$150.0M
raised

LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Fort Collins, United States
$75.0M
raised

Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.

Jul 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Sydney, Australia
$132.4M
raised

Clarity Pharmaceuticals is a personalized medicine company focused on the treatment of serious disease.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Würzburg, Germany
$23.2M
raised

Pentixapharm develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$60.0M
raised

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Jul 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 481 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 481 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked